Verve Therapeutics
VERV
#6836
Rank
C$0.64 B
Marketcap
$7.26
Share price
9.83%
Change (1 day)
-23.33%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -C$0.32 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are C$32.33 Million. a decrease over its 2023 earnings that were of -C$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.32 Billion2.48%
2023 -C$0.31 Billion34.67%
2022 -C$0.23 Billion90.3%
2021 -C$0.13 Billion114.31%
2020 -C$56.18 Million